Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia

Molecular Neurobiology

Volumn 44, Issue 1, 2011, Pages 102-110

  Purohit, Vishnudutt ^a   Rapaka, Rao ^a   Shurtleff, David ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Dopamine; Dopamine transporter; Drugs of abuse; gp120 Tat; HAD HAND; HIV SIV; Macrophage microglia

Indexed keywords

CHEMOKINE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; GLYCOPROTEIN GP 120; HYDROGEN PEROXIDE; LEVODOPA; METHAMPHETAMINE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SELEGILINE; SEMIQUINONE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; AUTOOXIDATION; CATECHOLAMINE BLOOD LEVEL; CELL ACTIVATION; CYTOKINE PRODUCTION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DRUG ABUSE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MICROGLIA; MURINE LEUKEMIA VIRUS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LOAD; VIRUS REPLICATION;

EID: 79960229299     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-011-8195-z     Document Type: Article

References (77)

1. DB Clifford 2008 HIV-associated neurocognitive disease continues in the antiretroviral era Top HIV Med 16 94 98 18591717
2. IC Anthony JE Bell 2008 The neuropathology of HIV/AIDS Int Rev Psychiatr 20 15 24 10.1080/09540260701862037 1:STN:280:DC%2BD1c%2Fot1CnsA%3D%3D (Pubitemid 351196199)
3. GJ Dore PK Correll Y Li JM Kaldor DA Cooper BJ Brew 1999 Changes to AIDS dementia complex in the era of highly active antiretroviral therapy AIDS 13 1249 1253 10416530 10.1097/00002030-199907090-00015 1:STN:280:DyaK1Mzkt12iuw%3D%3D (Pubitemid 29361096)
4. SA Thomas 2004 Anti-HIV drug distribution to the central nervous system Curr Pharm Des 10 1313 1324 15134483 10.2174/1381612043384835 1:CAS:528:DC%2BD2cXjsVyrtrw%3D (Pubitemid 38568084)
5. J Davies IP Everall S Weich J McLaughlin F Scaravilli PL Lantos 1997 HIV-associated brain pathology in the United Kingdom: an epidemiological study AIDS 11 1145 1150 9233462 10.1097/00002030-199709000-00010 1:STN:280: DyaK2sznslylsA%3D%3D (Pubitemid 27273612)
6. A Nath WF Maragos MJ Avison FA Schmitt JR Berger 2001 Acceleration of HIV dementia with methamphetamine and cocaine J Neurovirol 7 66 71 11519485 10.1080/135502801300069737 1:STN:280:DC%2BD3MvnsFKlug%3D%3D (Pubitemid 32904361)
7. SA Cristiani ND Pukay-Martin RA Bornstein 2004 Marijuana use and cognitive function in HIV-infected people J Neuropsychiatry Clin Neurosci 16 330 335 15377740 10.1176/appi.neuropsych.16.3.330 (Pubitemid 39244559)
8. JD Rippeth RK Heaton CL Carey TD Marcotte DJ Moore R Gonzalez T Wolfson I Grant HNRC Group 2004 Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons J Int Neuropsychol Soc 10 1 14 14751002 10.1017/S1355617704101021 1:CAS:528:DC%2BD2cXmvVGltQ%3D%3D (Pubitemid 38128457)
9. TH Burdo SN Katner MA Taffe HS Fox 2006 Neuroimmunity, drugs of abuse, and neuroAIDS J Neuroimmune Pharmacol 1 41 49 18040790 10.1007/s11481-005-9001-3 (Pubitemid 44257499)
10. MJ Ferris CF Mactutus RM Booze 2008 Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS Neurosci Biobehav Rev 32 883 909 18430470 10.1016/j.neubiorev.2008.01.004 1:CAS:528:DC%2BD1cXms1Whtr4%3D
11. G Di Chiara A Imperato 1988 Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci U S A 85 5274 5278 2899326 10.1073/pnas.85.14. 5274
12. FE Pontieri G Tanda G Di Chiara 1995 Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens Proc Natl Acad Sci U S A 92 12304 12308 8618890 10.1073/pnas.92.26. 12304 1:CAS:528:DyaK28Xhtl2nug%3D%3D (Pubitemid 26014059)
13. CW Bradberry 2000 Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use J Neurosci 20 7109 7115 10995858 1:CAS:528:DC%2BD3cXmvVGhsbw%3D
14. QD Walker CM Kuhn 2008 Cocaine increases stimulated dopamine release more in periadolescent than adult rats Neurotoxicol Teratol 30 412 418 18508233 10.1016/j.ntt.2008.04.002 1:CAS:528:DC%2BD1cXhtVymsr%2FI
15. AL Brody ED London RE Olmstead Z Allen-Martinez S Shulenberger MR Costello AL Abrams D Scheibal J Farahi S Shoptaw MA Mandelkern 2010 Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for tobacco dependence Psychiatr Res 183 218 224 10.1016/j. pscychresns.2009.06.004 1:CAS:528:DC%2BC3cXhtV2hsr3P
16. S Czub M Czub E Koutsilieri S Sopper F Villinger JG Müller C Stahl-Hennig P Riederer V Ter Meulen G Gosztonyi 2004 Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs Acta Neuropathol 107 216 226 14712399 10.1007/s00401-003-0801-3 1:CAS:528:DC%2BD2cXht1aitbo%3D (Pubitemid 38263411)
17. AM Kumar JB Fernandez EJ Singer D Commins D Waldrop-Valverde RL Ownby M Kumar 2009 Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains J Neurovirol 15 257 274 19499455 10.1080/13550280902973952 1:CAS:528: DC%2BD1MXhtVGrsrbK
18. PJ Gaskill TM Calderon AJ Luers EA Eugenin JA Javitch JW Berman 2009 Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse Am J Pathol 175 1148 1159 19661443 10.2353/ajpath.2009.081067 1:CAS:528:DC%2BD1MXhtF2isb3F
19. EH Aylward JD Henderer JC McArthur PD Brettschneider GJ Harris PE Barta GD Pearlson 1993 Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging Neurology 43 2099 2104 8413973 1:STN:280:DyaK2c%2FitVantw%3D%3D (Pubitemid 23318887)
20. MG Reyes F Faraldi CS Senseng C Flowers R Fariello 1991 Nigral degeneration in acquired immune deficiency syndrome (AIDS) Acta Neuropathol 82 39 44 1950477 10.1007/BF00310921 1:STN:280:DyaK38%2FlslKisg%3D%3D
21. K Itoh P Mehraein S Weis 2000 Neuronal damage of the substantia nigra in HIV-1 infected brains Acta Neuropathol 99 376 384 10787036 10.1007/s004010051139 1:STN:280:DC%2BD3c3ks1OitQ%3D%3D (Pubitemid 30179576)
22. GJ Dal Pan JH McArthur E Aylward OA Selnes TE Nance-Sproson AJ Kumar ED Mellits JC McArthur 1992 Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis Neurology 42 2125 2130 1436522 1:STN:280:DyaK3s%2Fmtl2juw%3D%3D
23. K Hestad JH McArthur GJ Dal Pan OA Selnes TE Nance-Sproson E Aylward VP Mathews JC McArthur 1993 Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance Acta Neurol Scand 88 112 118 8213054 10.1111/j.1600-0404.1993.tb04201.x 1:STN:280:DyaK2c%2Fis1WksA%3D%3D (Pubitemid 23247973)
24. R Paul R Cohen B Navia K Tashima 2002 Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1 Neurosci Biobehav Rev 26 353 359 12034135 10.1016/S0149-7634(02)00006-4 (Pubitemid 34553318)
25. JK Marcario KF Manaye KS SantaCruz PR Mouton NE Berman PD Cheney 2004 Severe subcortical degeneration in macaques infected with neurovirulent simian immunodeficiency virus J Neurovirol 10 387 399 15765810 10.1080/ 13550280490521131 1:CAS:528:DC%2BD2MXotFeruw%3D%3D (Pubitemid 40109626)
26. RK Fujimura K Goodkin CK Petito R Douyon DJ Feaster M Concha P Shapshak 1997 HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia J Acquir Immune Defic Syndr Hum Retrovirol 16 146 152 9390565 10.1097/00042560-199711010-00002 1:STN:280:DyaK1c%2FltV2gsw%3D%3D
27. K Kure KM Weidenheim WD Lyman DW Dickson 1990 Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration Acta Neuropathol 80 393 400 2239151 10.1007/BF00307693 1:STN:280:DyaK3M%2FltVeksA%3D%3D (Pubitemid 20255763)
28. AM Kumar I Borodowsky B Fernandez L Gonzalez M Kumar 2007 Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction J Neurovirol 13 210 224 17613711 10.1080/13550280701327038 1:CAS:528: DC%2BD2sXnt1Wjsr4%3D (Pubitemid 47050647)
29. AM Sardar C Czudek GP Reynolds 1996 Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS NeuroReport 7 910 8724671 10.1097/00001756-199603220-00015 1:STN:280:DyaK28zjt12mtw%3D%3D
30. K Kieburtz L Ketonen C Cox H Grossman R Holloway H Booth C Hickey A Feigin ED Caine 1996 Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection Arch Neurol 53 155 158 8639065 1:STN:280:DyaK283isFOitw%3D%3D (Pubitemid 26055262)
31. DA Rottenberg JJ Sidtis SC Strother KA Schaper JR Anderson MJ Nelson RW Price 1996 Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia J Nucl Med 37 1133 1141 8965184 1:STN:280: DyaK283mvVWnsg%3D%3D (Pubitemid 26329520)
32. JR Berger M Kumar A Kumar JB Fernandez B Levin 1994 Cerebrospinal fluid dopamine in HIV-1 infection AIDS 8 67 71 8011238 10.1097/00002030-199401000- 00010 1:STN:280:DyaK2c3otVOjtA%3D%3D (Pubitemid 24094090)
33. M Larsson L Hagberg A Forsman G Norkrans 1991 Cerebrospinal fluid catecholamine metabolites in HIV-infected patients J Neurosci Res 28 406 409 1856886 10.1002/jnr.490280313 1:STN:280:DyaK3MzhtFOisA%3D%3D
34. A di Rocco T Bottiglieri D Dorfman P Werner C Morrison D Simpson 2000 Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients Clin Neuropharmacol 23 190 194 11020122 10.1097/00002826-200007000-00004
35. M Obermann M Küper O Kastrup O Yaldizli S Esser J Thiermann E Koutsilieri G Arendt HC Diener M Maschke German Competence Network HIV/AIDS 2009 Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV J Neurol 256 948 953 19240951 10.1007/s00415-009-5052-3 1:CAS:528:DC%2BD1MXnsVais7k%3D
36. C Scheller G Arendt T Nolting C Antke S Sopper M Maschke M Obermann A Angerer IW Husstedt F Meisner E Neuen-Jacob HW Müller P Carey V Ter Meulen P Riederer E Koutsilieri 2010 Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses J Neural Transm 117 699 705 20454983 10.1007/s00702-010-0415-6 1:STN:280:DC%2BC3cznslWqsg%3D%3D
37. S Czub E Koutsilieri S Sopper M Czub C Stahl-Hennig JG Müller V Pedersen W Gsell JL Heeney M Gerlach G Gosztonyi P Riederer V ter Meulen 2001 Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs Acta Neuropathol 101 85 91 11271377 1:CAS:528:DC%2BD3MXht1aqu7Y%3D (Pubitemid 32124479)
38. C Scheller S Sopper M Jenuwein E Neuen-Jacob T Tatschner E Grünblatt V ter Meulen P Riederer E Koutsilieri 2005 Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation J Neurochem 95 377 387 16190867 10.1111/j.1471-4159.2005.03373.x 1:CAS:528:DC%2BD2MXhtFegu7vI (Pubitemid 41457506)
39. M Jenuwein C Scheller E Neuen-Jacob S Sopper T Tatschner V ter Meulen P Riederer E Koutsilieri 2004 Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeys J Neurovirol 10 163 170 15204921 10.1080/13550280490448016 1:CAS:528:DC%2BD2cXlsl2msr0%3D (Pubitemid 38868154)
40. M Czub S Czub G Gosztonyi E Koutsilieri S Sopper JG Müller M Gerlach P Riederer V ter Meulen 1999 Effects of selegiline in a retroviral rat model for neurodegenerative disease J Neurovirol 5 458 464 10568882 10.3109/13550289909045374 1:CAS:528:DyaK1MXntlSksLo%3D (Pubitemid 29484174)
41. O Rohr BE Sawaya D Lecestre D Aunis E Schaeffer 1999 Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system Nucleic Acids Res 27 3291 3299 10454636 10.1093/nar/27.16.3291 1:CAS:528:DyaK1MXls1SntL4%3D (Pubitemid 29381322)
42. C Scheller S Sopper C Jassoy V ter Meulen P Riederer E Koutsilieri 2000 Dopamine activates HIV in chronically infected T lymphoblasts J Neural Transm 107 1483 1489 11459001 10.1007/s007020070012 1:CAS:528:DC%2BD3MXivVGqu74%3D (Pubitemid 32049944)
43. MP Nair S Mahajan D Sykes MV Bapardekar JL Reynolds 2006 Methamphetamine modulates DC-SIGN expression by mature dendritic cells J Neuroimmune Pharmacol 1 296 304 18040806 10.1007/s11481-006-9027-1 (Pubitemid 44244134)
44. MP Nair ZM Saiyed N Nair NH Gandhi JW Rodriguez N Boukli E Provencio-Vasquez RM Malow MJ Miguez-Burbano 2009 Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells J Neuroimmune Pharmacol 4 129 139 18958626 10.1007/s11481-008-9128-0
45. H Liang X Wang H Chen L Song L Ye SH Wang YJ Wang L Zhou WZ Ho 2008 Methamphetamine enhances HIV infection of macrophages Am J Pathol 172 1617 1624 18458095 10.2353/ajpath.2008.070971 1:CAS:528:DC%2BD1cXnslKjs70%3D (Pubitemid 351793354)
46. BE Sawaya O Rohr D Aunis E Schaeffer 1996 Chicken ovalbumin upstream promoter transcription factor, a transcriptional activator of HIV-1 gene expression in human brain cells J Biol Chem 271 23572 23576 8798567 10.1074/jbc.271.38.23572 1:CAS:528:DyaK28XlvVyjtro%3D (Pubitemid 26314810)
47. O Rohr C Schwartz D Aunis E Schaeffer 1999 CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine J Cell Biochem 75 404 413 10536364 10.1002/(SICI)1097-4644(19991201)75:3<404::AID-JCB6>3.0.CO;2-G 1:CAS:528:DyaK1MXntFCmtLg%3D (Pubitemid 29521649)
48. J Cami D Farre 2003 Drug addiction N Engl J Med 349 975 986 12954747 10.1056/NEJMra023160 1:CAS:528:DC%2BD3sXntFeitrg%3D (Pubitemid 37064772)
49. TJ Volz GR Hanson AE Fleckenstein 2007 The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits J Neurochem 101 883 888 17250674 10.1111/j.1471-4159.2006. 04419.x 1:CAS:528:DC%2BD2sXmtFGkurk%3D (Pubitemid 46683868)
50. D Seger 2010 Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation Clin Toxicol (Phila) 48 695 708 1:CAS:528:DC%2BC3cXhtFOktLfF
51. MJ Ferris D Frederick-Duus J Fadel CF Mactutus RM Booze 2009 In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission Synapse 63 181 185 19086089 10.1002/syn.20594 1:CAS:528:DC%2BD1MXhsVCgt7g%3D
52. MJ Ferris D Frederick-Duus J Fadel CF Mactutus RM Booze 2009 The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study Neuroscience 159 1292 1299 19344635 10.1016/j.neuroscience.2009.01.024 1:CAS:528:DC%2BD1MXktFeksb4%3D
53. J Zhu CF Mactutus DR Wallace RM Booze 2009 HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes J Pharmacol Exp Ther 329 1071 1083 19325033 10.1124/jpet.108.150144 1:CAS:528:DC%2BD1MXms1egsr4%3D
54. S Hu WS Sheng JR Lokensgard PK Peterson RB Rock 2009 Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage J Neurovirol 15 401 410 20175694 10.3109/13550280903296346 1:CAS:528: DC%2BC3cXisVCgtLw%3D
55. GJ Wang L Chang ND Volkow F Telang J Logan T Ernst JS Fowler 2004 Decreased brain dopaminergic transporters in HIV-associated dementia patients Brain 127 2452 2458 15319273 10.1093/brain/awh269 (Pubitemid 39472973)
56. L Chang GJ Wang ND Volkow T Ernst F Telang J Logan JS Fowler 2008 Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse NeuroImage 42 869 878 18579413 10.1016/j.neuroimage.2008.05.011
57. MC Ritz RJ Lamb SR Goldberg MJ Kuhar 1987 Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science 237 1219 1223 2820058 10.1126/science.2820058 1:CAS:528:DyaL2sXls1yisr4%3D (Pubitemid 17131228)
58. SG Amara MJ Kuhar 1993 Neurotransmitter transporters: recent progress Annu Rev Neurosci 16 73 93 8096377 10.1146/annurev.ne.16.030193.000445 1:CAS:528:DyaK3sXktVSqur8%3D (Pubitemid 23074001)
59. DD Han HH Gu 2006 Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs BMC Pharmacol 6 6 16515684 10.1186/1471-2210-6-6
60. ME Reith MY Li QS Yan 1997 Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers Psychopharmacology (Berl) 134 309 317 10.1007/s002130050454 1:CAS:528:DyaK2sXnvFWiu74%3D (Pubitemid 27520985)
61. AE Fleckenstein RR Metzger DG Wilkins JW Gibb GR Hanson 1997 Rapid and reversible effects of methamphetamine on dopamine transporters J Pharmacol Exp Ther 282 834 838 9262348 1:CAS:528:DyaK2sXltlSntbk%3D (Pubitemid 27340185)
62. JM Kokoshka RA Vaughan GR Hanson AE Fleckenstein 1998 Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters Eur J Pharmacol 361 269 275 9865517 10.1016/S0014-2999(98)00741-9 1:CAS:528:DyaK1cXnvVSrtLY%3D (Pubitemid 29000982)
63. RR Metzger GR Hanson JW Gibb AE Fleckenstein 1998 3-4- Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function Eur J Pharmacol 349 205 210 9671099 10.1016/S0014-2999(98)00196-4 1:CAS:528:DyaK1cXjvVSlsrg%3D (Pubitemid 28277089)
64. JM Brown GR Hanson AE Fleckenstein 2000 Methamphetamine rapidly decreases vesicular dopamine uptake J Neurochem 74 2221 2223 10800970 10.1046/j.1471-4159.2000.0742221.x 1:CAS:528:DC%2BD3cXis12qsrk%3D (Pubitemid 30217682)
65. KA Hogan RG Staal PK Sonsalla 2000 Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations J Neurochem 74 2217 2220 10800969 10.1046/j.1471-4159.2000.0742217. x 1:CAS:528:DC%2BD3cXis12qsrg%3D (Pubitemid 30217681)
66. JM Brown GR Hanson AE Fleckenstein 2001 Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants J Pharmacol Exp Ther 296 762 767 11181904 1:CAS:528: DC%2BD3MXhtlOlu78%3D (Pubitemid 32187345)
67. H Khoshbouei H Wang JD Lechleiter JA Javitch A Galli 2003 Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism J Biol Chem 278 12070 12077 12556446 10.1074/jbc.M212815200 1:CAS:528:DC%2BD3sXisVOnsLw%3D (Pubitemid 36800184)
68. DG Graham 1978 Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol Pharmacol 14 633 643 98706 1:CAS:528:DyaE1cXlsF2is7w%3D (Pubitemid 8402469)
69. R Pedrosa P Soares-da-Silva 2002 Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (l-DOPA) and dopamine Br J Pharmacol 137 1305 1313 12466240 10.1038/sj.bjp.0704982 1:CAS:528:DC%2BD3sXktlWm (Pubitemid 36071748)
70. DM Kuhn DM Francescutti-Verbeem DM Thomas 2006 Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage Ann N Y Acad Sci 1074 31 41 17105901 10.1196/annals.1369.003 1:CAS:528:DC%2BD28XhtFGgs77J (Pubitemid 44532808)
71. MY Aksenov U Hasselrot AK Bansal G Wu A Nath C Anderson CF Mactutus RM Booze 2001 Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum Neurosci Lett 305 5 8 11356294 10.1016/S0304-3940(01)01786-4 1:CAS:528:DC%2BD3MXjsFeisbw%3D (Pubitemid 32436461)
72. CB Pocernich R Sultana H Mohmmad-Abdul A Nath DA Butterfield 2005 HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations Brain Res Brain Res Rev 50 14 26 15890409 10.1016/j.brainresrev. 2005.04.002 1:CAS:528:DC%2BD2MXht1SksrnL (Pubitemid 41607513)
73. M Toborek YW Lee H Pu A Malecki G Flora R Garrido B Hennig HC Bauer A Nath 2003 HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium Neurochem 84 169 179 10.1046/j.1471-4159.2003.01543.x 1:CAS:528:DC%2BD3sXhtF2htg%3D%3D (Pubitemid 36182077)
74. TO Price N Ercal R Nakaoke WA Banks 2005 HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells Brain Res 1045 57 63 15910762 10.1016/j.brainres.2005.03.031 1:CAS:528:DC%2BD2MXks1antr0%3D (Pubitemid 40725220)
75. CB Pocernich R Sultana E Hone J Turchan RN Martins V Calabrese A Nath DA Butterfield 2004 Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes J Neurosci Res 77 532 539 15264223 10.1002/jnr.20182 1:CAS:528:DC%2BD2cXmtlKmtbc%3D (Pubitemid 39007005)
76. L Agrawal JP Louboutin E Marusich BA Reyes EJ Van Bockstaele DS Strayer 2010 Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates Brain Res 1306 116 130 19815008 10.1016/j.brainres.2009. 09.113 1:CAS:528:DC%2BD1MXhsV2msbbO
77. JM Silvers MV Aksenova MY Aksenov CF Mactutus RM Booze 2007 Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor NeuroToxicology 28 1184 1190 17764744 10.1016/j.neuro.2007.07.005 1:CAS:528:DC%2BD2sXht1KkurnP (Pubitemid 350026595)